SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/24/13 Organovo Holdings, Inc. 10-KT 3/31/13 66:7.4M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: 10-KT Annual-Transition Report HTML 783K 2: EX-23.1 Consent of Experts or Counsel HTML 18K 3: EX-31.1 Certification -- §302 - SOA'02 HTML 23K 4: EX-31.2 Certification -- §302 - SOA'02 HTML 23K 5: EX-32.1 Certification -- §906 - SOA'02 HTML 22K 43: R1 Document and Entity Information HTML 48K 33: R2 Consolidated Balance Sheets HTML 129K 41: R3 Consolidated Balance Sheets (Parenthetical) HTML 33K 46: R4 Consolidated Statements of Operations HTML 83K 61: R5 Consolidated Statements of Stockholders' Equity HTML 134K (Deficit) 35: R6 Consolidated Statements of Cash Flows HTML 156K 40: R7 Consolidated Statements of Cash Flows HTML 47K (Parenthetical) 30: R8 Change in Fiscal Year End HTML 22K 22: R9 Description of Business and Summary of Significant HTML 96K Accounting Policies 62: R10 Fixed Assets HTML 37K 48: R11 Accrued Expenses HTML 29K 47: R12 Derivative Liability HTML 49K 52: R13 Convertible Notes Payable HTML 39K 53: R14 Stockholders' Equity HTML 112K 51: R15 Commitments and Contingencies HTML 44K 54: R16 Licensing Agreements and Research Contracts HTML 37K 42: R17 Income Taxes HTML 43K 45: R18 Concentrations HTML 26K 50: R19 Subsequent Events HTML 22K 66: R20 Description of Business and Summary of Significant HTML 191K Accounting Policies (Policies) 57: R21 Description of Business and Summary of Significant HTML 49K Accounting Policies (Tables) 37: R22 Fixed Assets (Tables) HTML 35K 49: R23 Accrued Expenses (Tables) HTML 28K 39: R24 Derivative Liability (Tables) HTML 34K 16: R25 Stockholders' Equity (Tables) HTML 91K 58: R26 Commitments and Contingencies (Tables) HTML 40K 63: R27 Licensing Agreements and Research Contracts HTML 28K (Tables) 26: R28 Income Taxes (Tables) HTML 35K 25: R29 Description of Business and Summary of Significant HTML 32K Accounting Policies (Details) 28: R30 Description of Business and Summary of Significant HTML 38K Accounting Policies (Details 1) 29: R31 Description of Business and Summary of Significant HTML 283K Accounting Policies (Details Textual) 31: R32 Fixed Assets (Details) HTML 41K 15: R33 Fixed Assets (Details Textual) HTML 23K 55: R34 Accrued Expenses (Details) HTML 34K 36: R35 Derivative Liability (Details) HTML 34K 38: R36 Derivative Liability (Details Textual) HTML 39K 19: R37 Convertible Notes Payable (Details) HTML 230K 65: R38 Stockholders' Equity (Details) HTML 34K 12: R39 Stockholders' Equity (Details 1) HTML 59K 32: R40 Stockholders' Equity (Details 2) HTML 36K 60: R41 Stockholders' Equity (Details 3) HTML 49K 18: R42 Stockholders' Equity (Details 4) HTML 24K 24: R43 Stockholders' Equity (Details Textual) HTML 375K 27: R44 Commitments and Contingencies (Details) HTML 33K 34: R45 Commitments and Contingencies (Details 1) HTML 28K 14: R46 Commitments and Contingencies (Details 2) HTML 46K 21: R47 Commitments and Contingencies (Details Textual) HTML 34K 13: R48 Licensing Agreements and Research Contracts HTML 28K (Details) 59: R49 Licensing Agreements and Research Contracts HTML 83K (Details Textual) 17: R50 Income Taxes (Details) HTML 51K 56: R51 Income Taxes (Details Textual) HTML 48K 20: R52 Subsequent Events (Details Textual) HTML 29K 64: XML IDEA XML File -- Filing Summary XML 102K 23: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 1.16M 6: EX-101.INS XBRL Instance -- onvo-20130331 XML 1.38M 8: EX-101.CAL XBRL Calculations -- onvo-20130331_cal XML 193K 9: EX-101.DEF XBRL Definitions -- onvo-20130331_def XML 623K 10: EX-101.LAB XBRL Labels -- onvo-20130331_lab XML 1.38M 11: EX-101.PRE XBRL Presentations -- onvo-20130331_pre XML 981K 7: EX-101.SCH XBRL Schema -- onvo-20130331 XSD 201K 44: ZIP XBRL Zipped Folder -- 0001193125-13-235652-xbrl Zip 160K
EX-31.2 |
Exhibit 31.2
CERTIFICATION
I, Barry D. Michaels, Chief Financial Officer of Organovo Holdings, Inc., certify that:
1. I have reviewed this transition report on Form 10-K of Organovo Holdings, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the consolidated financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting
Dated: May 24, 2013 |
||
Barry D. Michaels | ||
Chief Financial Officer | ||
(Principal Financial and Accounting Officer) |
This ‘10-KT’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 5/24/13 | |||
For Period end: | 3/31/13 | 8-K | ||
List all Filings |